共 23 条
[1]
Gavras H., Liang C., Brunner H.R., Redistribution of regional blood flow after inhibition of the angiotensin converting enzyme, Circ Res, 43, pp. 59-63, (1978)
[2]
Takeyama K., Minato H., Nakatsuji K., Et al., Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals, Arzneimittelforsch, 36, pp. 69-73, (1986)
[3]
Richer C., Doussau M., Giudicelli J., Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat, Am J Cardiol, 59, pp. 12D-17D, (1987)
[4]
Barry D.I., Jarden J.O., Paulson O.B., Et al., Cerebrovascular aspects of converting-enzyme inhibition I: effects of in-travenous captopril in spontaneously hypertensive and normotensive rats, J Hypertens, 2, pp. 589-597, (1984)
[5]
Jarden J.O., Barry D.I., Juhler M., Et al., Cerebrovascular aspects of converting-enzyme inhibition II: blood-brain barrier permeability and effect of intracerebroventricular administration of captopril, J Hypertens, 2, pp. 599-604, (1984)
[6]
Paulson O.B., Waldemar G., Andersen A.R., Et al., Role of angiotensin in autoregulation of cerebral blood flow, Circulation, 77, pp. 55-58, (1988)
[7]
Waldemar G., Pedersen E.V., Barry D.I., Cerebral blood flow autoregulation during angiotensin converting enzyme inhibition (abst), J Cereb Blood Flow Metabol, 7, (1987)
[8]
Waldemar G., Schmidt J.F., Andersen A.R., Et al., Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man, J Hypertens, 7, pp. 229-235, (1989)
[9]
Minematsu K., Yamaguchi T., Tsuchiya M., Et al., Effect of angiotensin converting enzyme inhibitor (captopril) on cerebral blood flow in hypertensive patients without a history of stroke, Clin Exp Hypertens, A9, pp. 551-557, (1987)
[10]
Frei A., Miiller-Brand J., Cerebral blood flow and antihy-pertensive treatment with enalapril, J Hypertens, 4, pp. 365-367, (1986)